Illumina offices. Credit: Rick Starkman/Illumina Top EU Court Deals Commission's New Merger Approach Major Blow
U.S. gene sequencing company Illumina won its court fight against the European Union regarding its acquisition of Grail when the EU's top court ruled that an expanded control approach pursued by Brussels officials since 2021 to go after killer acquisitions breaches EU law.
September 03, 2024 at 11:21 AM
4 minute read
Antitrust
The EU's top court ruled Tuesday that an expanded merger control approach pursued by Brussels officials to go after killer acquisitions since 2021 violates EU rules—a decision that marks a major victory for U.S. biotech giant Illumina.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Law Firms Mentioned
Trending Stories
- 1Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 2The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 3The 'Biden Effect' on Senior Attorneys: Should I Stay or Should I Go?
- 4BD Settles Thousands of Bard Hernia Mesh Lawsuits
- 5'You Are Not Alone': 120 Sex Assault Victims Plan to Sue Sean 'Diddy' Combs
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
